{"schema_version":"1","generated_at":"2026-11-04T08:00:57.423Z","data_as_of":null,"url":"https://www.findmykol.com/kol/joseph-bodor","json_url":"https://www.findmykol.com/kol/joseph-bodor/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"joseph-bodor","name":"Joseph Bodor","credential":"MD, PhD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Fox Chase Cancer Center","institution_url":"https://www.findmykol.com/institution/fox-chase-cancer-center","city":"Philadelphia","state":"PA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1528486586","orcid":"0000-0001-5209-4502","openalex":"A5030983210"},"summary":"Joseph Bodor is an Oncology physician affiliated with Fox Chase Cancer Center. OpenAlex indexes 64 publications with 2,594 citations (h-index 18); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":64,"cited_by_count":2594,"h_index":18,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT03786692","title":"Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC","phase":"PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"Fox Chase Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT03786692","trial_url":"https://www.findmykol.com/trial/NCT03786692"}],"source":"trials"},"payments":{"company_count":7,"program_years":{"first":2021,"last":null},"rows_total":13,"shown":3,"withheld":10,"rows":[{"payer":"Eli Lilly","program_year":2025,"amount_usd":332296.92,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1528486586"},{"payer":"Genentech","program_year":2025,"amount_usd":62169,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1528486586"},{"payer":"AstraZeneca UK Limited","program_year":2025,"amount_usd":1920,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1528486586"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1528486586","source":"payments"},"prescribing":{"data_year":2024,"areas_total":6,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":40.3,"classes_total":1,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":40.3,"drugs":[{"name":"Tagrisso","share_pct":53.6},{"name":"Gilotrif","share_pct":19.6},{"name":"Alecensa","share_pct":13.4},{"name":"Alunbrig","share_pct":13.4}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":21.6,"classes_total":3,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":10.1,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":22},{"class":"Corticosteroid","setting":"prescribed","share_pct":7.2,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":15}]},{"area":"Nervous system","share_pct":16.9,"classes_total":3,"classes":[{"class":"Partial Opioid Agonist","setting":"prescribed","share_pct":6.1,"drugs":[{"name":"Buprenorphine","share_pct":100}],"max_beneficiaries":null},{"class":"Atypical Antipsychotic","setting":"prescribed","share_pct":5.4,"drugs":[{"name":"Olanzapine","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2024,"last":2024},"rows_total":1,"shown":1,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R21CA282851","title":"Estrogen Suppression as a Strategy to Enhance Immunotherapy Efficacy in EGFR-Mutated Non-Small Cell Lung Cancer","fiscal_year":2024,"amount_usd":"483395","organization":"RESEARCH INST OF FOX CHASE CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/R21CA282851"}],"source":"grants"},"contact":{"address_1":"333 COTTMAN AVE","city":"Philadelphia","state":"PA","zip":"191112434","phone":"215-728-2500","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1528486586","source":"identity"},"similar":[{"name":"Elizabeth Plimack","slug":"elizabeth-plimack","institution":"Fox Chase Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/elizabeth-plimack","json_url":"https://www.findmykol.com/kol/elizabeth-plimack/profile.json"},{"name":"Martin Edelman","slug":"martin-edelman","institution":"Fox Chase Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/martin-edelman","json_url":"https://www.findmykol.com/kol/martin-edelman/profile.json"},{"name":"Shazia Nakhoda","slug":"shazia-nakhoda","institution":"Fox Chase Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/shazia-nakhoda","json_url":"https://www.findmykol.com/kol/shazia-nakhoda/profile.json"},{"name":"Robert Uzzo","slug":"robert-uzzo","institution":"Fox Chase Cancer Center","specialty":"Urology","url":"https://www.findmykol.com/kol/robert-uzzo","json_url":"https://www.findmykol.com/kol/robert-uzzo/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":10}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-05-27","provider_certified":"2021-05-27","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}